THE EARLY EFFECTS OF RADIOIODINE THERAPY FOR HYPERTHYROIDISM ON BIOCHEMICAL INDEXES OF BONE TURNOVER

被引:35
作者
MACLEOD, JM
MCHARDY, KC
HARVEY, RD
DUNCAN, A
REID, IW
BEWSHER, PD
ROBINS, SP
机构
[1] UNIV ABERDEEN, DEPT MED & THERAPEUT, POLWARTH BLDG, ABERDEEN AB9 2ZD, SCOTLAND
[2] UNIV ABERDEEN, DEPT CLIN BIOCHEM, ABERDEEN AB9 2ZD, SCOTLAND
[3] ROWETT RES INST, BUCKSBURN AB2 9SB, ABERDEEN, SCOTLAND
关键词
D O I
10.1111/j.1365-2265.1993.tb00972.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE We investigated the early changes following radioiodine therapy for hyperthyroidism, in biochemical indices of bone synthesis and degradation, and their relationship to circulating thyroid hormone concentrations. DESIGN Prospective follow-up over the first 12 weeks after radioiodine therapy. PATIENTS Six women with clinical and biochemical evidence of hyperthyroidism. MEASUREMENTS Serum concentrations of T4, free T3 and osteocalcin, and urinary excretion of the pyridinium cross-links, pyridinaline and deoxypyridinaline, measured before and weekly for 12 weeks after administration of radioiodine. therapy. RESULTS Biochemical indices of bone metabolism were elevated prior to treatment. There was a brisk reduction in circulating thyroid hormones levels paralleled by a similar fall in pyridinium cross-link excretion, which had returned to normal in five patients by the end of the study. There was a positive correlation between pyridinium cross-link excretion and thyroid hormone concentrations. There was no significant change in serum osteocalcin. CONCLUSIONS Treatment of hyperthyroidism results in prompt correction of the associated increased rate of bone collagen degradation suggesting that effective early correction of hyperthyroidism is desirable to limit its detrimental effect on skeletal mass.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 37 条
[11]  
HARVEY RD, 1991, THESIS ABERDEEN U, P167
[12]  
HARVEY RD, 1991, J CLIN ENDOCRINOLOGY, V72, P258
[13]  
HEYMA P, 1980, ENDOCRINOLOGY, V106, P1437, DOI 10.1210/endo-106-5-1437
[14]   SPINAL BONE-MINERAL CONTENT IN MYXEDEMA AND THYROTOXICOSIS - EFFECTS OF THYROID HORMONE(S) AND ANTI-THYROID TREATMENT [J].
KROLNER, B ;
JORGENSEN, JV ;
NIELSEN, SP .
CLINICAL ENDOCRINOLOGY, 1983, 18 (05) :439-446
[15]   SERUM OSTEOCALCIN IS INCREASED IN PATIENTS WITH HYPERTHYROIDISM AND DECREASED IN PATIENTS RECEIVING GLUCOCORTICOIDS [J].
LUKERT, BP ;
HIGGINS, JC ;
STOSKOPF, MM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (05) :1056-1058
[16]  
MARTIN TJ, 1988, BAILLIERE CLIN ENDOC, V2, P1
[17]  
MELSEN F, 1977, ACTA PATH MICRO IM A, V85, P141
[18]   EFFECT OF PROPRANOLOL TREATMENT ON BONE MASS, BONE-MINERAL CONTENT, BONE REMODELING, PARATHYROID FUNCTION AND VITAMIN-D METABOLISM IN HYPERTHYROIDISM [J].
MOSEKILDE, L ;
JASTRUP, B ;
MELSEN, F ;
LUND, B ;
LUND, B ;
SORENSEN, OH ;
NIELSEN, HE ;
YDE, H .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1984, 14 (02) :96-102
[19]   EFFECTS OF THYROID-HORMONES ON BONE AND MINERAL METABOLISM [J].
MOSEKILDE, L ;
ERIKSEN, EF ;
CHARLES, P .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1990, 19 (01) :35-63
[20]   BONE-RESORBING ACTIVITY IN SUPERNATANTS FROM LYMPHOID-CELL LINES [J].
MUNDY, GR ;
LUBEN, RA ;
RAISZ, LG ;
OPPENHEIM, JJ ;
BUELL, DN .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (16) :867-871